Bhagyashree Srivastava

Ms. Bhagyashree Srivastava

Banasthali University, Jaipur, India
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2022 in BioTech
Verified
Journal Article
Open access
PDF file
CPChetan Pandit
Chetan Pandit
BTBhim Sen Thapa
Bhim Sen Thapa
Bhagyashree SrivastavaBhagyashree Srivastava
Bhagyashree Srivastava
AMAbhilisha Singh Mathuriya
Abhilisha Singh Mathuriya
UTUmair Ali Toor
Umair Ali Toor
Dipak A. JadhavDipak A. Jadhav
Dipak A. Jadhav
Due to the continuous depletion of natural resources currently used for electricity generation, it is imperative to develop alternative energy sources. Human waste is nowadays being explored as an efficient source to produce bio-energy. Human waste is renewable and can be used as a source for an uninterrupted energy supply in bioelectricity or biofuel. Annually, human waste such as urine is produced in trillions of liters globally. Hence, utilizing the waste to produce bioenergy is bio-economically suitable and ecologically balanced. Microbial fuel cells (MFCs) play a crucial role in providing an effective mode of bioelectricity production by implementing the role of transducers. MFCs convert organic matter into energy using bio-electro-oxidation of material to produce electricity. Over the years, MFCs have been explored prominently in various fields to find a backup for providing bioenergy and biofuel. MFCs involve the role of exoelectrogens which work as transducers to convert the material into electricity by catalyzing redox reactions. This review paper demonstrates how human waste is useful for producing electricity and how this innovation would be beneficial in the long term, considering the current scenario of increasing demand for the supply of products and shortages of natural resources used to produce biofuel and bioelectricity.

6 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
YRYesheswini Rajendran
Yesheswini Rajendran
Bhagyashree SrivastavaBhagyashree Srivastava
Bhagyashree Srivastava
PGPreksha Gaur
Preksha Gaur
RBRohan Babar
Rohan Babar
NGNeha Guliya
Neha Guliya
CSChittur V. Srikanth
Chittur V. Srikanth
Inflammatory bowel disease (IBD), comprising Ulcerative colitis (UC) and Crohn’s Disease, is a chronic relapsing immune-mediated inflammatory disorder of the gut. The intestinal mucus layer is a protective barrier that safeguards direct exposure of epithelium to luminal microbes and antigens. A prolonged disruption of the mucus layer may contribute to the development of IBD. Loss of mucin-producing goblet cells is a hallmark of UC. The underlying molecular mechanism controlling goblet regulation remains poorly understood. In the current work, we show a key role for NCoR1 (Nuclear corepressor 1) in goblet cell regulation. A specific downregulation of NCoR1 in intestinal crypts and goblet cells was observed in human UC and mice models. While NCoR1 was upregulated during goblet cell differentiation, inflammatory cues downregulated its expression. Experimental loss of NCoR1 resulted in exacerbated disease in a murine model of colitis, whereas its upregulation via Vitamin D led to a rescue. ChIP-seq led to the identification of KLF-16, a transcription factor, as a target of NCoR1. NCoR1 -KLF16 regulatory axis regulated key goblet cell proteins, including MUC2. Mechanistically, the regulation of MUC2 is modulated by the NCoR1-KLF16 axis, via mTOR signalling. In conclusion, this work shows a critical involvement of NCoR1-KLF16 in governing goblet cell function and intestinal homeostasis.